Intellia Therapeutics is a Massachusetts-based biotechnology company that researches and develops genome editing therapies to treat genetic and oncological diseases.
Business Model:
Revenue: $51.4M
Employees: 201-500
Address: 40 Erie Street
City: Cambridge
State: MA
Zip: 02139
Country: US
Intellia Therapeutics is a Massachusetts-based biotechnology company that researches and develops genome editing therapies to treat genetic and oncological diseases.
Contact Phone:
+18572856200
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
5/6/2016
IPO Valuation:
$772M
Ticker Symbol:
NTLA
IPO Price:
$22/share
Amount Raised:
$108M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
1/2022 | Kyverna Therapeutics | Series B | 0 |
10/2021 | SparingVision | Corporate Round | - |
1/2022 | Kyverna Therapeutics | Series B | 0 |
10/2021 | SparingVision | Corporate Round | - |
Announced Date | Name | Price |
---|---|---|
2/2022 | Rewrite Therapeutics |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|